{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T12:13:47Z","timestamp":1763468027152},"reference-count":22,"publisher":"Japan Atherosclerosis Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT"],"published-print":{"date-parts":[[2005]]},"DOI":"10.5551\/jat.12.251","type":"journal-article","created":{"date-parts":[[2011,6,16]],"date-time":"2011-06-16T13:45:32Z","timestamp":1308231932000},"page":"251-259","source":"Crossref","is-referenced-by-count":18,"title":["Lipid, Lipoprotein, Apolipoprotein and Lipoprotein(a) Levels: Reference Intervals in a Healthy Indian Population"],"prefix":"10.5551","volume":"12","author":[{"given":"Tester F.","family":"Ashavaid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Altaf A.","family":"Kondkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seema P.","family":"Todur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alpa J.","family":"Dherai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaysingh","family":"Morey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rani","family":"Raghavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.19.2486"},{"key":"2","doi-asserted-by":"crossref","unstructured":"(2) Djurovic S and Berg K: Epidemiology of Lp(a) lipoprotein: its role in atherosclerotic\/thrombotic disease. Clin Genet, 52: 289−292, 1997","DOI":"10.1111\/j.1399-0004.1997.tb04345.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"(3) Graziani MS, Zanolla L, Righetti G, Marchetti C, Mocarell P, and Marcovina SM: Plasma apolipoproteins A-I and B in survivors of myocardial infarction and in a control group. Clin Chem, 44: 134−140, 1998","DOI":"10.1093\/clinchem\/44.1.134"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)07098-2"},{"issue":"12","key":"5","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0022-2275(20)34443-6","volume":"25","author":"Mahley, R. W., Innerarity, T. L., R","year":"1984","ISSN":"http:\/\/id.crossref.org\/issn\/0022-2275","issn-type":"print"},{"key":"6","doi-asserted-by":"crossref","unstructured":"(6) Jungner I, Marcovina SM, Walldius G, Holme I, Kolar W, and Steiner E: Apolipoprotein B and A-I values in 147 576 Swedish males and females, standardized according to the World Health Organization-International Federation of Clinical Chemistry First International Reference Materials. Clin Chem, 44: 1641−1649, 1998","DOI":"10.1093\/clinchem\/44.8.1641"},{"key":"7","unstructured":"(7) Dati F and Tate J: Reference materials for the standardization of the apolipoproteins A-I and B, and lipoprotein(a). eJIFCC, 13 (3): http:\/\/www.ifcc.org\/ejifcc\/vol13no3\/130301003.htm"},{"key":"8","doi-asserted-by":"crossref","unstructured":"(8) Vincent-Viry V, Schiele F, Guegen R, Bohnet K, Visvikis S, and Siest G: Biological variations and genetic reference values for apolipoprotein E serum concentrations: results from the STANISLAS cohort study. Clin Chem, 44: 657−65, 1998","DOI":"10.1093\/clinchem\/44.5.957"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M200006-JLR200"},{"key":"10","doi-asserted-by":"crossref","unstructured":"(10) Hattori Y, Suzuki M, Tsushima M, Yoshida M, Tokunaga Y, Wang Y, Zhao D, Takeuchi M, Hara Y, Ryomoto KI, Ikebuchi M, Kishioka H, Mannami T, Baba S, and Harano Y: Development of approximate formula for LDL-chol, LDL-apo B and LDL-chol\/LDL-apo B as indices of hyperapobetalipo-proteinemia and small dense LDL. Atherosclerosis, 138: 289−299, 1998","DOI":"10.1016\/S0021-9150(98)00034-3"},{"key":"11","doi-asserted-by":"crossref","unstructured":"(11) Contois J, McNamara JR, Lammi-Keefe C, Wilson PW, Massov T, and Schaefer EJ: Reference intervals for plasma apolipoprotein A-I determined with a standardized commercial immunoturbidimetric assay: results from Framingham Offspring Study. Clin Chem, 42: 507−514, 1996","DOI":"10.1093\/clinchem\/42.4.507"},{"key":"12","doi-asserted-by":"crossref","unstructured":"(12) Contois J, McNamara JR, Lammi-Keefe CJ, Wilson PW, Massov T, and Schaefer EJ: Reference intervals for plasma apolipoprotein B determined with a standardized commercial immunoturbidimetric assay: results from Framingham Offspring Study. Clin Chem, 42: 515−523, 1996","DOI":"10.1093\/clinchem\/42.4.515"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(91)90106-M"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-8981(01)00591-5"},{"key":"15","doi-asserted-by":"crossref","unstructured":"(15) Kottke BA, Moll PP, Michels VV, and Weidman WH: Levels of Lipids, Lipoproteins, and apolipoproteins in a defined population. Mayo Clin Proc, 66: 1198−1208, 1991","DOI":"10.1016\/S0025-6196(12)62470-7"},{"key":"16","unstructured":"(16) Ashavaid TF, Todur SP, and Dherai AJ: Health status of Indian population-current scenario. J Assoc Physicians India, 52: 363−369, 2004"},{"key":"17","unstructured":"(17) Enas EA, Davidson MA, Garg A, Nair VM, and Yusuf S: Prevalence of coronary heart disease and its risk factors in Asian Indian migrants to the United States Proc Int Symp atherosclerosis, Rosemont, II, Oct, 6−11, 1991"},{"key":"18","doi-asserted-by":"crossref","unstructured":"(18) Sniderman AD, Wolfson C, Teng B, Franklin FA, Bachorik PS, and Kwiterovich PO Jr: Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis. Ann Intern Med, 97: 833, 1982","DOI":"10.7326\/0003-4819-97-6-833"},{"key":"19","unstructured":"(19) Dherai AJ, Kondkar AA, and Ashavaid TF: Determination of low density lipoprotein subfractions in normolipemic individuals. Indian J Cardiol, 6: 41-45, 2003."},{"key":"20","unstructured":"(20) Misra A, Luthra K, and Vikram NK: Dyslipidemia in Asian Indians: determinants and significance. JAPI 2004; 52: 137−142."},{"key":"21","doi-asserted-by":"crossref","unstructured":"(21) Lamarche B, Moorjani S, Lupien PJ, Cantin B, Bernard PM, Dagenais GR, and Despres JP: Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Quebec cardiovascular study. Circulation, 94: 273−278, 1996","DOI":"10.1161\/01.CIR.94.3.273"},{"key":"22","unstructured":"(22) Chopra V and Wasir HS: Implications of lipoprotein abnormalities in Indian patients. J Assoc Physicians India, 46: 814−818, 1998"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/12\/5\/12_5_251\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T09:48:59Z","timestamp":1637833739000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jat\/12\/5\/12_5_251\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.12.251","relation":{},"ISSN":["1880-3873","1340-3478"],"issn-type":[{"value":"1880-3873","type":"electronic"},{"value":"1340-3478","type":"print"}],"subject":[],"published":{"date-parts":[[2005]]}}}